Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post GOP senators express ‘concerns,’ ‘skepticism’ over Trump’s spending bill after Musk rant June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Albemarle Swings to Profit, Lowers Spending Amid Prolonged Lithium Slump August 2, 2025 Crypto Market Update: Markets Pull Back After Fed Holds Interest Rates Steady August 2, 2025 Silver Crown Provides Corporate Update August 2, 2025